LLY

1,144.58

+1.28%↑

JNJ

232.3

-0.15%↓

ABBV

222.66

-2.06%↓

UNH

405.72

+1.35%↑

MRK

119.23

-1.41%↓

LLY

1,144.58

+1.28%↑

JNJ

232.3

-0.15%↓

ABBV

222.66

-2.06%↓

UNH

405.72

+1.35%↑

MRK

119.23

-1.41%↓

LLY

1,144.58

+1.28%↑

JNJ

232.3

-0.15%↓

ABBV

222.66

-2.06%↓

UNH

405.72

+1.35%↑

MRK

119.23

-1.41%↓

LLY

1,144.58

+1.28%↑

JNJ

232.3

-0.15%↓

ABBV

222.66

-2.06%↓

UNH

405.72

+1.35%↑

MRK

119.23

-1.41%↓

LLY

1,144.58

+1.28%↑

JNJ

232.3

-0.15%↓

ABBV

222.66

-2.06%↓

UNH

405.72

+1.35%↑

MRK

119.23

-1.41%↓

Search

Quidel Corp

Geschlossen

14.5 1.54

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

13.95

Max

14.75

Schlüsselkennzahlen

By Trading Economics

Einkommen

39M

-92M

Verkäufe

-104M

620M

Gewinnspanne

-14.811

Angestellte

6,500

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

-16.11% downside

Dividenden

By Dow Jones

Nächstes Ergebnis

4. Aug. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

62M

762M

Vorheriger Eröffnungskurs

12.96

Vorheriger Schlusskurs

14.5

Quidel Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

8. Juni 2026, 22:20 UTC

Akquisitionen, Fusionen, Übernahmen

Salesforce to Buy m3ter in Nod Toward AI-Native Business Models

8. Juni 2026, 15:41 UTC

Wichtige Markttreiber

American Battery Shares Jump on Energy Department Victory

8. Juni 2026, 23:46 UTC

Market Talk

Nikkei May Rebound After Monday's Selloff -- Market Talk

8. Juni 2026, 23:37 UTC

Market Talk

Oil Edges Higher Amid Ongoing Supply Disruption Concerns -- Market Talk

8. Juni 2026, 23:25 UTC

Market Talk

Should Australia Consider State-Linked Commodities Export Desk? -- Market Talk

8. Juni 2026, 23:25 UTC

Market Talk

Global Equities Roundup: Market Talk

8. Juni 2026, 21:57 UTC

Akquisitionen, Fusionen, Übernahmen

Salesforce Expects to Close Deal in 2Q of Fiscal 2027

8. Juni 2026, 21:56 UTC

Akquisitionen, Fusionen, Übernahmen

Salesforce Agrees to Buy m3ter

8. Juni 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

8. Juni 2026, 19:22 UTC

Market Talk

Oil Settles Higher as Israel-Iran Exchanges Raise Tension -- Market Talk

8. Juni 2026, 19:01 UTC

Market Talk

U.S. Natural Gas Futures Pull Back on Weather Outlook -- Market Talk

8. Juni 2026, 18:52 UTC

Market Talk

Global Energy Roundup: Market Talk

8. Juni 2026, 18:52 UTC

Market Talk

CAD Needs Trade Deal to Trigger Sustained Rally -- Market Talk

8. Juni 2026, 18:17 UTC

Market Talk

Oil Pulls Back Further As Iran, Israel Put Strikes on Hold -- Market Talk

8. Juni 2026, 17:32 UTC

Market Talk

Bank of Canada Should Incorporate Unemployment Rate Into Its Forecast -- Market Talk

8. Juni 2026, 17:29 UTC

Market Talk

Crypto Market Still Stays in 'Extreme Fear' Amid Rebound -- Market Talk

8. Juni 2026, 17:29 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

8. Juni 2026, 16:55 UTC

Akquisitionen, Fusionen, Übernahmen

Monte dei Paschi: Mediobanca Integration Proceeding According to Plan

8. Juni 2026, 16:54 UTC

Akquisitionen, Fusionen, Übernahmen

Monte dei Paschi to Review Proposals From Banco BPM, Intesa Sanpaolo

8. Juni 2026, 16:40 UTC

Market Talk

Cryptocurrencies Rise After Iran and Israel Halt Exchanges of Fire -- Market Talk

8. Juni 2026, 16:31 UTC

Market Talk

No Recession in Canada, Scotiabank's CEO Says -- Market Talk

8. Juni 2026, 16:27 UTC

Market Talk

Mexican Inflation Seen Easing in May -- Market Talk

8. Juni 2026, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

8. Juni 2026, 16:03 UTC

Akquisitionen, Fusionen, Übernahmen

Orange Bought Stake From Lorca

8. Juni 2026, 16:01 UTC

Akquisitionen, Fusionen, Übernahmen

Orange Completes Acquisition of Remaining 50% Stake in MasOrange

8. Juni 2026, 16:01 UTC

Akquisitionen, Fusionen, Übernahmen

Orange Acquires 100% Ownership of MasOrange

8. Juni 2026, 15:58 UTC

Market Talk

Global Equities Roundup: Market Talk

8. Juni 2026, 15:58 UTC

Market Talk

Gold Trims Losses After Israel, Iran Halt Exchanges of Fire -- Market Talk

8. Juni 2026, 15:55 UTC

Market Talk

Markets Price Small Chance USMCA Will Be Dismantled -- Market Talk

8. Juni 2026, 15:41 UTC

Market Talk

Gold Falls Below 200-Day Moving Average -- Market Talk

Peer-Vergleich

Kursveränderung

Quidel Corp Prognose

Kursziel

By TipRanks

-16.11% Nachteil

12-Monats-Prognose

Durchschnitt 12.13 USD  -16.11%

Hoch 13 USD

Tief 11 USD

Basierend auf 6 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Quidel Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

6 ratings

1

Buy

4

Halten

1

Sell

Finanzen

Vertriebs- und Verwaltungskosten

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

Betriebsergebnis

$

Über Quidel Corp

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.
help-icon Live chat